RNA Treatments and Vaccines for Infectious Disease Response

14 Sep, 2020 | Newsletters
RNA Treatments and Vaccines for Infectious Disease Response
RNA-based genetic vaccines may represent the most promising approach for the rapid development and deployment of a COVID-19 vaccine. 

This symposium discusses the current landscape and the opportunities RNA treatments compared to DNA and conventional vaccines. Speakers provide an introductory overview of RNA platform technologies; future pandemic preparedness; and the Target Product Profile (TPP) for RNA vaccines.

Dr. Andy Geall – What is Required in a Successful mRNA Vaccine Program – Recording
Dr. Bijoyita Roy – The Anatomy of an mRNA and its Synthesis In Vitro – Recording
Dr. Lloyd Jeffs – A Framework for Developing RNA Medicine – Recording
Dr. Yvonne Perrie – Delivery Options for RNA: Exploiting Nanoparticles – Recording
Dr. Andy Geall – RNA Vaccine Demonstration – Recording  

CONTACT US FOR A FREE DEMO NOW    

NANOASSEMBLR ON DEMAND WEBINARS   

Is RNA Medicine the Next Paradigm Shift? PNI-CRS Local Chapter

This talk will highlight unique features of EVs for RNA delivery and discuss novel approaches that may contribute to the development of more efficient EV-based RNA
delivery systems. 
 
Use of PNI Microfluidics to Manufacture GMP Quality siRNA Nanoparticles

Sirnaomics, first company to use the NanoAssemblr® GMP System with NxGen technology to produce nanoparticles containing 2 siRNAs under GMP conditions
discusses their work.
 
Lipid Based Nanomedicine – Challenges that Lead to Solutions

Dr. Bally discusses 35 years of research and new nanomedicines, mainly Myocet- for metastatic breast cancer, Marqibo- for relapsed ALL & Vyxeos, for high-risk AML.

 
Small molecule delivery systems prepared with microfluidics

This talk explores the ways that the efficacy of a small molecule drug can be increased, both through the production, and microfluidic control over the development of a suitable delivery system.  
NANOASSEMBLR DEMONSTRATION VIDEOS

NanoAssemblr Ignite Demo
Ignite with NxGen microfluidics reproducibly generates optimal particles through a single mixer across scales, saving time and money.
CLICK HERE TO WATCH NOW

NanoAssemblr Blaze Demo
With NanoAssemblr Blaze, important studies can be conducted efficiently with a process that mirrors a clinical scale implementation.
CLICK HERE TO WATCH NOW

NanoAssemblr GMP Demo
Configurable & modular system that enables manufacturing scales 200 ml to greater than 100 L.
CLICK HERE TO WATCH NOW